Sanofi buys UK’s Kymab and inflammatory disease hopeful for $1.45bn
Record number of health firms feature in UK top 100 private tech list
UK and Chinese antibody companies collaborate in immuno-oncology
Kymab signs immuno-oncology deal for bi-specific antibodies
Biotech’s Kymouse could hold the key to vaccines.
UK’s Kymab could help develop HIV vaccine
Kymab, F-star and Mission Therapeutics among crop of new UK biotechs.
Will the UK ever produce a world-class biotech company?